Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy - Carreau, Nicole A.; Armand, Philippe; Merryman, Reid W.; Advani, Ranjana H.; Spinner, Michael A.; Herrera, Alex F.; Ramchandren, Radhakrishnan; Hamid, Muhammad S.; Assouline, Sarit; Santiago, Raoul; Wagner‐Johnston, Nina; Paul, Suman; et al. (British journal of haematology, 2020)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Allografts; chemosensitivity; Chemotherapy; Chimeric antigen receptors; Clinical trials; Disease-Free Survival; Female; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immune checkpoint; Immune Checkpoint Inhibitors - administration & dosage; immunotherapy; Immunotherapy, Adoptive; Lymphocytes T; Lymphoma; Lymphoma, Non-Hodgkin - mortality; Lymphoma, Non-Hodgkin - therapy; Male; Middle Aged; Non-Hodgkin's lymphoma; non‐Hodgkin lymphoma; Patients; Retrospective Studies; Survival Rate; Transplantation Conditioning; Tumors; chemosensitivity; non-Hodgkin lymphoma; immunotherapy